Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT)

Institut de cancérologie Strasbourg Europe

Status: Completed

Conditions: Hematologic Malignancy; Tumor, Solid

Study type: Observational

Funder types: Other

Identifiers

NCT04628234

2020-A00439-30 (Other Identifier)

2020-001

Details and patient eligibility

About

This is a non randomized, monocentric, descriptive, transversal and prospective study. The purpose of this study is to assess the compliance with patient expressed choice regarding subsequent care and death -if occured- site (at hospital or at home) after hospitalisation for terminally ill patients with an onco-hematologic solid tumor in palliative care and to identify reasons for potential non-compliance.

Full description

Patients will reply to two questionnaires, at inclusion and two months after inclusion. Primary care physician will also be contacted by phone to reply to two questionnaires, at inclusion and two months after inclusion.

Enrollment: 53 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must be ≥ 18 years old
• Patients with onco-hematologic solid tumor (locally advanced or metastatic) against which specific and systemic treatments are outdated or have been stopped (symptomatic palliation with radiotherapy is allowed)
• Patients admitted in full hospitalisation
• Patients able to speak, read and understand French
• Patients able to answer the phone
• Signed informed consent from the patient
• Patients must have a social security coverage

Exclusion criteria

• Patients < 18 years old or incapable person ≥ 18 years old
• Patients admitted for any surgical intervention
• Patients unable to read French
• Patients whose physical or psychological condition do not allow them to answer orally or in writing
• Patients deprived of liberty
• Patients placed under judicial protection
• Women that are pregnant or breast-feeding

Trial design

53 participants in 1 patient group

Patients with an onco-hematologic solid tumor in palliative care